Delivery Order SPE2DB22D2006-SPE2DB24FW2ZB
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$82K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,283.38 firm fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion to the government. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $8,914.71 delivery order is for the supply of RESTASIS 0.05% Eye Emulsion, a prescription medication, and has a firm fixed-price structure. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded various indefinite delivery contracts (IDCs) by DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,921.89, is for the delivery of Restasis 0.05% eye emulsion in 60-count units. The contract is a firm fixed-price delivery order with an ultimate completion date of October 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed price delivery order valued at $9,303.69 to Amerisourcebergen Drug Corporation for the supply of RESTASIS 0.4ML 30S pharmaceutical product. The award is part of Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $20,878.42 firm fixed price delivery order is for the supply of RESTASIS 0.05% eye emulsion to DLA. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,052.66 firm-fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of June 30, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,160.96, is for the delivery of RESTASIS 0.05% eye emulsion to support military treatment programs and facilities. The contract is a firm fixed-price delivery order with an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award is a delivery order valued at $2,352.00 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RESTASIS 0.05% eye emulsion, a prescription ophthalmic medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award, identified as SPE2DX15D3017 and SPE2DX24F0LJA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $6,938.49 firm fixed price delivery order is for the supply of Restasis 0.05% eye emulsion, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
This federal contract award is for pharmaceutical products and medical supplies provided to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,120.75, is for the delivery of Restasis 0.05% eye emulsion and has an ultimate completion date of November 1, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant...